Alerts will be sent to your verified email
Verify Email
BACPHAR
|
Bacil Pharma
|
Shelter Pharma
|
Asston Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-69.0 % | 18.24 % | 31.69 % |
|
5yr average Equity Multiplier
|
1.36 | 1.33 | 5.73 |
|
5yr Average Asset Turnover Ratio
|
0.0 | 1.65 | 0.79 |
|
5yr Avg Net Profit Margin
|
0.0 | 10.09 % | 10.83 % |
|
Price to Book
|
2.58 | 1.52 | 6.53 |
|
P/E
|
92.45 | 8.98 | 16.14 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 138.55 Days | 121.8 Days |
|
Inventory Days
|
0.0 | 71.81 Days | 31.3 Days |
|
Days Receivable
|
0.0 | 66.01 Days | 296.65 Days |
|
Days Payable
|
0.0 | 6.41 Days | 343.23 Days |
|
5yr Average Interest Coverage Ratio
|
-943.72 | 84.13 | 3.57 |
|
5yr Avg ROCE
|
-75.56 % | 25.47 % | 42.37 % |
|
5yr Avg Operating Profit Margin
|
0.0 | 14.81 % | 15.11 % |
|
5 yr average Debt to Equity
|
0.05 | 0.03 | 1.99 |
|
5yr CAGR Net Profit
|
n/a | 182.84 % | 108.46 % |
|
5yr Average Return on Assets
|
-70.2 % | 13.79 % | 7.75 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.08 % | 52.32 % | 50.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-42.59 % | -4.57 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Bacil Pharma
|
Shelter Pharma
|
Asston Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|